BridgeBio Pharma Inc (BBIO)

24.10 -0.69 (-2.78%) USD  |  NASDAQ  |  Nov 14, 16:00
24.10 0.00 (0.00%) After-Hours: 18:19
More

BridgeBio Pharma Non-Current Deferred Revenue (Quarterly)

Non-Current Deferred Revenue (Quarterly) Chart

View Non-Current Deferred Revenue (Quarterly) for BBIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Non-Current Deferred Revenue (Quarterly) Data

View and export this data back to 2024. Upgrade now.
Date Value
June 30, 2024 --
Date Value
March 31, 2024 --

Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years

Upgrade
Minimum
Jun 2024
Upgrade
Maximum
Mar 2024
Upgrade
Average
Upgrade
Median

Non-Current Deferred Revenue (Quarterly) Benchmarks

Alnylam Pharmaceuticals Inc Upgrade
Pfizer Inc --
Vertex Pharmaceuticals Inc --
PTC Therapeutics Inc --
Bristol-Myers Squibb Co Upgrade